[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100637676":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":10,"centralContacts":28,"locations":34,"responsibleParty":51,"collaborators":10,"id":55,"slug":10,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":58,"acronym":10,"eligibilityCriteria":59,"healthyVolunteers":56,"sex":60,"minAge":61,"maxAge":10,"enrollmentInfo":62,"targetDuration":65,"studyType":66,"phases":10,"briefSummary":67,"conditions":68,"keywords":10,"overallStatus":37,"whyStopped":10,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Tongji Hospital","OTHER",[8,13],{"label":9,"type":10,"description":10,"interventionNames":11},"Liver resection group",null,[12],"Procedure: liver resection",{"label":14,"type":10,"description":10,"interventionNames":15},"Non-surgery group",[16],"Drug: Systemic therapy combined with locoregional interventions",[18,23],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"PROCEDURE","liver resection","Patients undergo liver resection for tumor.",[9],{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":10},"DRUG","Systemic therapy combined with locoregional interventions","Patients recieve PD-1 inhibitors combined with targeted drugs and locoregional interventions",[14],[29],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},"Qi Cheng, M.D.","CONTACT","13871459541","chengqi@hust.edu.cn",[35],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology","RECRUITING","Wuhan","Hubei","430030","China","CN",{"type":44,"coordinates":45},"Point",[46,47],114.26667,30.58333,{"lat":47,"lon":46},[50],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},{"type":52,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Cheng Qi","Deputy Director of Hepatobiliary and Pancreatic Surgery Department","100637676",false,"NCT07587216","Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment","Inclusion Criteria:\n\n* Male or female aged ≥18 years at the time of signing the informed consent form\n* Clinically or histologically confirmed diagnosis of liver cancer\n* Recieving treatment and follow-up in Tongji Hospital\n\nExclusion Criteria:\n\n\\- Refuse participanting in this study","ALL","18 Years",{"count":63,"type":64},800,"ESTIMATED","2 Years","OBSERVATIONAL","This study is a prospective, observational, real-world cohort study. We aim to establish a prospective database in the Department of Hepatobiliary and Pancreatic Surgery, systematically collecting and integrating patients' full-course diagnostic and therapeutic information along with long-term outcomes. This will enable objective evaluation of prognosis and treatment efficacy in real-world clinical practice, while providing a data foundation and evidence support for subsequent optimization of clinical decision-makin",[69],"Liver Cancer (Primary and Metastatic)","2026-06-02",{"date":72,"type":73},"2026-06-04","ACTUAL",{"date":75,"type":73},"2026-01-01",{"date":77,"type":64},"2029-12-31",{"name":5,"class":6},1]